临床外科杂志 ›› 2024, Vol. 32 ›› Issue (6): 603-606.doi: 10.3969/j.issn.1005-6483.2024.06.013

• 论著 • 上一篇    下一篇

手术入路对食管癌根治术病人并发症及肿瘤标志物水平的影响

刘胜凯 崔丽娜 李俊鹏 石俊杰 范艳玲   

  1. 056000 河北省邯郸市第一医院
  • 收稿日期:2023-06-21 出版日期:2024-06-20 发布日期:2024-06-20
  • 通讯作者: 李俊鹏,Email:liminxue88@ 126.com
  • 基金资助:
    河北省邯郸市科学技术研究与发展计划项目(22422083072ZC)

Effect of surgical approach on complications and tumor marker levels in patients undergoing radical resection of esophageal cancer

LIU Shengkai,CUI Lina,LI Junpeng,SHI Junjie,FAN Yanling   

  1. Handan First Hospital,Han Dan,Hebei 056000,China
  • Received:2023-06-21 Online:2024-06-20 Published:2024-06-20

摘要: 目的 观察不同手术入路对食管癌根治术病人并发症及肿瘤标志物水平的影响。方法 2019年10月~2022年10月行根治术治疗的食管癌病人100例,采用随机数表法分为观察组和对照组,每组各50例,观察组使用右胸入路手术治疗,对照组使用左胸入路手术治疗。比较两组围术期指标、手术前后炎症因子[P物质(SP)、超敏C反应蛋白(hs-CRP)、白细胞介素(IL)-6]、肿瘤标志物[细胞角蛋白19片段抗原(CYFRA21-1)、鳞状细胞癌抗原(SCC-Ag)以及糖类抗原199(CA199)]、肺功能指标[肺活量(VC)、用力肺活量(FVC)以及第1秒用力呼气容积(FEV1)]以及并发症发生率。结果 观察组手术时间、失血量、留置胸管时间、住院时间以及淋巴结清扫数目分别为(247.65±27.33)分钟、(211.82±25.49)ml、(6.97±2.12)天、(16.11±3.81)天、(19.67±5.21)枚,均高于对照组[(217.63±23.69)分钟、(175.67±22.13)ml、(5.43±1.80)天、(12.68±3.24)天、(15.45±4.12)枚],差异有统计学意义(P<0.05);术后3天两组SP、hs-CRP、IL-6水平均有显著上升,差异有统计学意义(P<0.05),观察组术后3天SP、hs-CRP、IL-6水平分别为(273.96±35.45)ng/L、(11.35±2.12)mg/L、(8.19±1.67)μg/ml,低于对照组[(298.33±38.42)ng/L、(14.29±2.68)mg/L、(10.35±1.82)μg/ml],差异有统计学意义(P<0.05);术后1个月两组CYFRA21-1、SCC-Ag、CA199均有显著下降,差异有统计学意义(P<0.05),且观察组术后1个月CYFRA21-1、SCC-Ag、CA199分别为(2.59±0.37)μg/L、(45.62±6.18)μg/L、(59.37±6.12)U/ml低于对照组[(3.12±0.43)μg/L、(60.27±7.35)μg/L、(63.28±6.49)U/ml],差异有统计学意义(P<0.05);术后1个月两组VC、FVC、FEV1均显著下降,但观察组术后1个月VC、FVC、FEV1分别为(67.21±8.69)%、(70.33±9.41)%、(72.88±10.12)%高于对照组[(54.35±8.27)%、(61.65±8.79)%、(65.37±9.24)%],差异有统计学意义(P<0.05);两组并发症发生率比较,差异无统计学意义(P>0.05)。结论 两种入路方式均可有效治疗食管癌,其中右胸入路可明显提高淋巴结清扫效果,抑制炎症反应,降低肿瘤标志物水平,且对肺功能影响更小,未明显增加并发症风险,但手术时间、出血量及术后恢复时间相对较长,临床应结合病人实际选择合适的入路方式。

关键词: 右胸入路;左胸入路;食管癌;肺功能;并发症

Abstract: Objective To observe the effects of different surgical approaches on the complications and tumor markers of patients undergoing radical resection of esophageal cancer.Method A prospective study was conducted on 100 patients with esophageal cancer who underwent radical surgery in our hospital from October 2019 to October 2022.They were randomly divided into an observation group and a control group using a random number table method,with 50 patients in each group,he right thoracic approach was used in the observation group and the left thoracic approach was used in the control group.Perioperative indexes,inflammatory factors [Substance P (SP),hypersensitive C-reactive protein (hs-CRP),interleukin6 (IL-6)],tumor markers [cytokeratin 19 fragment antigen (CYFRA21-1),squamous cell carcinoma antigen (SCC-Ag) and carbohydrate antigen 199 (CA199)] and lung function of the two groups were compared before and after surgery Indicators [vital capacity (VC),forced vital capacity (FVC),and forced expiratory volume in the first second (FEV1)] and complication rate.Result The operating time,blood loss,indwelling time,hospitalization time,and number of lymph node dissection in the observation group were (247.65±27.33) minutes,(211.82±25.49) ml,(6.97 ± 2.12) days,(16.11±3.81)days ,and (19.67±5.21),respectively,which were higher than those in the control group[(217.63±23.69)minutes,(175.67±22.13)ml,(5.43±1.80)days,(12.68±3.24)days,(15.45±4.12)] (P<0.05).On average,there was a significant increase in SP,hs CRP,and IL-6 levels in both groups 3 days after surgery (P<0.05).The levels of SP,hs CRP,and IL-6 in the observation group were (273.96±35.45) ng/L,(11.35±2.12) mg/L,and (8.19±1.67)μg/ml,respectively,which were lower than the control group [(298.33±38.42)ng/L,(14.29±2.68)mg/L,(10.35±1.82)μg/ml](P<0.05);One month after surgery,there was a significant decrease in CYFRA21-1,SCC-Ag,and CA199 in both groups (P<0.05),and in the observation group,the data of CYFRA21-1,SCC-Ag,and CA199 were (2.59±0.37)μg/L,(45.62±6.18) μg/L and (59.37±6.12) U/ml,respectively,which were lower than those in the control group [(3.12±0.43)μg/L,(60.27±7.35)μg/L,(63.28±6.49)U/ml](P<0.05);One month after surgery,there was a significant decrease in VC,FVC,and FEV1 in both groups (P<0.05).However,the VC,FVC,and FEV1 in the observation group were (67.21±8.69)%,(70.33±9.41)%,and (72.88±10.12)%,respectively,which were higher than those in the control group [(54.35±8.27)%,(61.65±8.79)%,(65.37±9.24)%](P<0.05).There was no significant difference in the incidence of complications between the two groups (P>0.05).Conclusion Both approaches can effectively treat esophageal cancer.Among them,the right chest approach can significantly improve the effect of lymph node dissection,inhibit inflammatory reactions,reduce tumor marker levels,and have less impact on lung function,without significantly increasing the risk of complications.However,the surgical time,bleeding volume,and postoperative recovery time are relatively long.Therefore,a suitable approach should be selected in clinical practice based on the patient’s actual situation.

Key words: right thoracic approach;left thoracic approach;esophageal cancer;lung function;complication

No related articles found!
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!